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Abstract
Understanding the control of mitochondrial energy metabolism is central to knowing how mitochondria function within
cells. Metabolic control analysis is the best approach available for studying the control of mitochondrial energy metabolism.
Here I outline how metabolic control analysis has been used to help understand mitochondrial regulation, damage and
pharmacology. ß 2001 Elsevier Science B.V. All rights reserved.
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1. Introduction
Historically there has been considerable interest in
understanding how mitochondrial energy metabolism
is controlled (e.g. [1] and reviewed in [2^4]). This has
led to insights into the mechanism and regulation of
oxidative phosphorylation and energy metabolism at
the cell, tissue and whole organism level. In other
studies, metabolic control analysis (MCA) was devel-
oped as an e¡ective theoretical and experimental
framework for investigating the control and regula-
tion of metabolic systems and was then applied to
oxidative phosphorylation. In addition to oxidative
phosphorylation mitochondria are involved in ther-
mogenesis, cell death, radical production, modula-
tion of calcium homeostasis and mitochondrial dam-
age contributes to a number of pathologies [5]. Here
I discuss how understanding the control of mito-
chondrial energy metabolism can be used to investi-
gate physiological, pathological and pharmacological
changes in mammalian mitochondria.
2. What controls mitochondrial energy metabolism?
There have been many extensive reviews of mito-
chondrial energy metabolism and the following is a
summary of their ¢ndings; I encourage you to read
these reviews [2^4,6^8].
2.1. A brief historical perspective
Early in the study of mitochondrial function it was
recognised that respiration and ATP synthesis were
coupled [9] (Fig. 1). Chance and colleagues showed
that respiration rate increased when mitochondria
synthesised more ATP and this led to the concept
of respiratory control, in which ADP supply to mi-
tochondria stimulated respiration and ATP synthesis
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[1]. This useful idea linked the rate of mitochondrial
ATP synthesis to cellular ATP demand by a feed-
back mechanism. It was extended to consider
whether transport of ATP across the mitochondrial
inner membrane by the adenine nucleotide carrier
was an important control [10], and whether ATP
demand was sensed by mitochondria through ADP
concentration, cellular or mitochondrial ATP/ADP
ratio, the phosphorylation potential or the energy
charge (reviewed in [3,4,6]). The mechanism by which
ATP demand a¡ected respiration became clear with
the development of the chemiosmotic coupling hy-
pothesis: ATP synthesis decreased vWH thus stimu-
lating the respiratory chain to pump more protons
across the mitochondrial inner membrane and main-
tain vWH [11]. However, control of mitochondrial
energy metabolism by ATP demand alone was in-
complete because electron supply to the respiratory
chain also a¡ected respiration and ATP synthesis.
For example, Denton and coworkers showed that
calcium stimulated mitochondrial matrix dehydro-
genases, increasing electron supply to the respiratory
chain and thus the rates of respiration and ATP syn-
thesis [12,13]. Therefore, respiration and ATP syn-
thesis respond to both the ‘pull’ of ATP consumption
and the ‘push’ of increased electron supply to the
respiratory chain. One approach to integrating these
two forces was the near-equilibrium hypothesis,
which considered the reactions of oxidative phos-
phorylation prior to cytochrome oxidase to be close
to equilibrium with all control residing in the non-
equilibrium step catalysed by cytochrome oxidase [2].
Another approach was to use non-equilibrium ther-
modynamics to represent £uxes such as respiration as
functions of the thermodynamic driving forces for
ATP synthesis (vGp) and of the redox reactions be-
tween reduced substrates and oxygen (vEh) [14].
While these, along with many other studies, laid
the foundations of our understanding of the control
and regulation of mitochondrial energy metabolism,
they did not lead directly to a comprehensive and
widely applicable description of the control of mito-
chondrial oxidative phosphorylation. Instead, MCA
emerged as the most useful theory for understanding
the control of oxidative phosphorylation.
2.2. MCA
MCA arose in response to the ambiguities inherent
in discussing the control of metabolic processes [15^
21]. A key ¢rst step in applying MCA to a metabolic
system is to de¢ne what is meant by control, which is
generally used vaguely and often interchangeably
with regulation. As shown in Fig. 2, an activity
such as an enzyme (E1) controls the overall £ux
(J), another enzyme activity (E2) or the size of a
metabolite pool (B) only if changing the activity of
E1 alters the magnitude of J, the activity of E2 or the
size of B. Control is quite distinct from regulation,
which implies a telelogical endpoint that is physio-
logically relevant, and system components with sub-
stantial control may not regulate the system in vivo.
The system being studied by MCA must be explicitly
de¢ned, because the question ‘what controls a £ux?’
depends critically on the system limits. For example,
the answer to ‘what controls fatty acid oxidation?’
depends on whether the system is the whole body,
the liver or the mitochondria: for the body adipose
tissue lipases have signi¢cant control while for the
liver the plasma fatty acid concentration is critical
and for mitochondria membrane transport becomes
important. In practice, system limits are usually set
by boundary substrate and product metabolites
which are at constant concentrations (e.g. A and C
in Fig. 2). The system is in a steady state and within
it are a series of enzymes and transport processes
connected by metabolite pools. The ¢nal considera-
tion is that control of the £uxes and metabolite con-
Fig. 1. Mitochondrial oxidative phosphorylation.
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centrations within this system is a property of the
whole system, not an isolated property of a particu-
lar enzyme. When the activity of an enzyme changes
in a metabolic system, all connected metabolite pools
and enzyme activities alter as the system adjusts to a
new steady state. This idea is central to MCA and is
a major shift from the text book idea of one rate
limiting step within a metabolic pathway.
The mathematical formulation of MCA was devel-
oped in parallel with these concepts [15,17] and the
nomenclature is now agreed upon [19,21] (see Fig. 2).
The £ux control coe⁄cient relates changes in a path-
way £ux to alterations in the activity of a particular
enzyme or transporter. This is de¢ned as the frac-
tional change in £ux that occurs following a frac-
tional change in the amount of the enzyme, hence
a step with a substantial £ux control coe⁄cient has
signi¢cant control over £ux. The elasticity coe⁄cient
indicates how the activity of an individual enzyme or
transporter responds to changes in its substrates,
products or other e¡ectors. This is de¢ned as the
fractional change in enzyme activity in response to
a fractional change in the e¡ector. The response co-
e⁄cient indicates how a system £ux changes in re-
sponse to an external e¡ector. It is de¢ned as the
fractional change in £ux in response to a fractional
change in the e¡ector, or alternatively as the product
of the £ux control coe⁄cient and the elasticity of
that enzyme to the e¡ector. The £ux control and
elasticity coe⁄cients of a system are all interrelated.
From the summation theorem, all the control coef-
¢cients over a £ux in a pathway sum to one, making
explicit that control is distributed throughout the
system. The connectivity theorem relates the £ux
control coe⁄cients of steps connected by a common
intermediate to their elasticities to that intermediate.
Hence a step with substantial elasticity to its sub-
strates is unlikely to have a high £ux control coe⁄-
cient because lowering its activity is opposed by the
build up of substrate. There are many further de¢-
nitions and theorems that have been developed to
account for branched pathways, feedback loops
and displacement from the steady state that are be-
yond the scope of this outline [19,21].
The application of MCA to metabolism has helped
to re¢ne and clarify thinking about metabolic con-
trol, but most importantly it has enabled the design
and interpretation of experiments. Even so there are
a number of theoretical and practical limitations to
MCA. The pattern of control described by MCA is
explicitly de¢ned for one set of conditions, therefore
even a small change could radically alter the distri-
bution of control within the system. While this can
make it di⁄cult to use the information obtained
under di¡erent conditions, the distribution of control
obtained by MCA is often su⁄ciently similar over a
range of conditions to make it useful in practice. A
further limitation is that control and regulation are
quite distinct concepts and it can be di⁄cult to use
MCA to study how metabolic systems change in re-
sponse to physiological signals. The ¢nal limitation is
experimental in that measurement of the £ux control
Fig. 2. Application of MCA to a simple metabolic pathway.
The upper section shows a simple metabolic pathway compris-
ing the metabolite pools A, B and C interconnected by the en-
zymes E1 and E2 while J is the overall £ux through the path-
way. In the lower section some of the equations used in MCA
are shown. The control coe⁄cient (CvP ) describes the fractional
change in a system property (NV/V) in response to a fractional
change in a system parameter (NP/P) as the change in the sys-
tem parameter tends to zero and all else is unchanged. For ex-
ample, the £ux control coe⁄cient of E1 over the £ux J for the
metabolic pathway shown above is CJ E1 = Dln J/Dln E1. The
elasticity coe⁄cient OES describes the change in the activity of
the enzyme E in response to changes in the concentration of
its substrate S. For the simple metabolic pathway above the
elasticity of E2 to its substrate B is OE2B = Dln E2/Dln B. The sum-
mation theorem states that the sum of the £ux control coe⁄-
cients for enzymes in the pathway is one. For the pathway
above, CJ E1+CJ E2 = 1. The connectivity theorem states that
the products of the £ux control coe⁄cient and the elasticity
to a substrate S for all enzymes connected by that substrate
S sum to zero. For example, for the pathway above,
CJ E1WOE1B +C
J
E1WOE2B = 0.
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coe⁄cients and elasticities in complicated systems
can be di⁄cult. Many of these di⁄culties can now
be overcome by theoretical and experimental devel-
opments, such as application of the top-down ap-
proach. MCA and our understanding of the con-
trol of mitochondrial oxidative phosphorylation
have developed in parallel, as is discussed in the
Section 2.3.
2.3. Application of MCA to mitochondrial oxidative
phosphorylation
The ¢rst application of MCA to mitochondrial
oxidative phosphorylation was to determine the
£ux control coe⁄cients of the various components
of mitochondrial oxidative phosphorylation over res-
piration in isolated mitochondria [22,23]. This was
done by titration with irreversible inhibitors of mito-
chondrial enzymes and transporters, relating the de-
crease in their activity to changes in respiration. This
approach is now termed the bottom up approach,
because the description of control develops from an-
alysing individual system components [7,8]. These
classic experiments gave two signi¢cant insights:
the control of respiration and ATP synthesis was
distributed throughout the mitochondrial oxidative
phosphorylation system and this distribution of con-
trol shifted as the metabolic state of the mitochon-
dria changed [22,23]. The redistribution of control
with change in metabolic state was important be-
cause mitochondria change from state 4, where res-
piration is low, vWH is high and there is no ATP
synthesis, to state 3 where respiration is high and
vWH is lowered by maximal ATP synthesis. Within
cells mitochondria are most often intermediate be-
tween states 3 and 4. In isolated mitochondria the
major control over state 4 respiration is the proton
leak through the mitochondrial inner membrane. As
mitochondria shift to a state intermediate between
state 4 and state 3 control by the proton leak de-
creases, and that by the adenine nucleotide carrier,
the dicarboxylate carrier, cytochrome oxidase and
the ATP consuming reactions increase. In state 3,
where ATP synthesis is maximal, most of the control
is by the respiratory chain and substrate transport
[6,22^24]. The bottom up approach has been applied
to a range of mitochondria from di¡erent species and
tissues and the same general pattern of distribution
of control between proton leak, the respiratory chain
and the phosphorylating system is retained, although
the distribution of £ux control between the steps
within these systems varies [6,23^26].
While the bottom up approach is useful for study-
ing the distribution of control in isolated mitochon-
dria, limitations of this approach are that the system
components must be known and that measuring the
£ux control coe⁄cients by titration with irreversible
inhibitors is di⁄cult in cells and organs. This led to
the development of the top-down approach, also
known as top-down elasticity analysis or modular
analysis [7,27,28]. In top-down elasticity analysis
the metabolic system is grouped into a few blocks
of reactions that either feed into or consume a com-
mon intermediate [27]. By determining the elasticities
of these blocks to the common intermediate the over-
all £ux control coe⁄cients of the blocks can be de-
termined [27]. In applying the top-down approach to
mitochondrial oxidative phosphorylation the system
is usually divided into three blocks connected by the
membrane potential (Fig. 3; the vpH component of
vWH is usually considered negligible relative to the
far larger and more easily measured membrane po-
tential [28]). The membrane potential is generated by
one block of reactions (substrate transport, metabo-
lism and the respiratory chain) and consumed by two
other blocks, the proton leak through the mitochon-
drial inner membrane and the reactions of ATP syn-
thesis, transport and turnover [27,28]. The elasticities
of the three subsystems to their common intermedi-
ate are then determined from appropriate uncoupler
or inhibitor titrations and the connectivity theorem
used to determine the £ux control coe⁄cients of the
Fig. 3. Top-down analysis of oxidative phosphorylation.
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three blocks over respiration, ATP synthesis or the
proton leak [28].
This approach simpli¢es complex systems both
conceptually and experimentally, making it useful
for analysing metabolic control in cells and organs
as well as isolated mitochondria [29]. Furthermore, it
does not make assumptions about the composition
of the blocks of reactions in the system and the ex-
periments are relatively straightforward, even in
complicated systems. However, some potential weak-
nesses of this approach are that all the pathways
generating and consuming the common intermediate
must be known, the various reaction blocks can only
interact through the single intermediate and any
changes in vpH must be negligible [85]. When top-
down analysis is applied to isolated mitochondria,
the major control over respiration in state 4 is the
proton leak with some control by the substrate oxi-
dation system [30], while in state 3 the major controls
are the phosphorylating system and the respiratory
chain. In states intermediate between states 3 and 4
the control shifts from leak to the phosphorylating
system with some control by the substrate oxidation
system [28]. This distribution of control is similar for
mitochondria isolated from a range of tissues and
organisms and is consistent with the distribution of
control within isolated mitochondria determined by
bottom up analysis [6,22]. Because only a few varia-
bles are measured, the top-down approach can be
applied to the control of respiration and ATP syn-
thesis in more complicated systems such as intact
cells, perfused organs and whole organisms
[29,31,32]. For example, in intact rat hepatocytes
from fed or starved animals the control of respira-
tion was largely by ATP synthesis and consumption
with the rest of the control distributed between the
proton leak and the reactions that generate the mem-
brane potential [29]. The top-down approach can
also extend outwards from mitochondria to integrate
the control of mitochondrial function with that of
related metabolic blocks such as glycolysis, pyruvate
oxidation and cellular ATP consumption [31,33].
3. Regulation of oxidative phosphorylation
The application of MCA to oxidative phosphory-
lation gives a good description of how control is
distributed throughout the system, and how this dis-
tribution changes when the system shifts to a new
steady state. A challenge now is to use this under-
standing of control to study how mitochondria are
regulated under physiological conditions. We know
that mitochondrial function is regulated by a number
of factors over a range of time scales [4]. These in-
clude rapid, reversible signals such as calcium stim-
ulating NADH supply to the respiratory chain [12]
or by directly or indirectly a¡ecting oxidative phos-
phorylation complex activities [34,35], nitric oxide
inhibiting cytochrome oxidase [36,37], or thyroid
hormones binding to cytochrome oxidase [38]. There
are also long-term alterations to mitochondrial func-
tion following changes in the expression of nuclear or
mitochondrial genes in response to hormonal or de-
velopmental signals: some examples are the long-
term e¡ects of thyroid hormones on mitochondrial
function [39,40], the changes in mitochondrial con-
tent and activity on exercising [41] and the altera-
tions to mitochondria that occur during development
[42]. The physiological endpoint for this regulation of
mitochondria is often to match ATP supply to
changes in workload, but it may also be for other
reasons such as to modulate thermogenesis, biogen-
esis or cell death [5,43].
In all these situations we want to understand how
the changes in mitochondrial function are brought
about. At ¢rst sight it may seem easy to use the
distribution of the control of oxidative phosphoryla-
tion provided by MCA to study regulation. How-
ever, regulation implies a physiological outcome
brought about by manipulating mitochondrial func-
tion, and this is quite distinct from control. Even so,
it might be expected that physiological e¡ectors
would manipulate mitochondrial function by altering
system components with substantial £ux control co-
e⁄cients. However, many physiological signals to
mitochondria cause large alterations in activity asso-
ciated with a major redistribution of control, such as
in the shift from state 4 to state 3. Consequently,
MCA has little power to predict where within a sys-
tem external e¡ectors will act to bring about a phys-
iological outcome. Instead MCA describes the new
pattern of control that arises when the system
reaches a steady state after stimulation. The wide-
spread assumption that e¡ectors only act through
steps with high £ux control coe⁄cients indicates
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how pervasive the concept of a single rate limiting
step remains.
This lack of predictive power of MCA is a frus-
tration that is being addressed in a number of ways.
One approach is to integrate MCA into mathemat-
ical models of metabolic systems (e.g. [44^46]). A
developing approach that has been applied experi-
mentally is that of regulation analysis which can be
used to determine the interactions that are important
in mediating £ux changes [8,47]. This approach de-
scribes how the system responds to external e¡ectors
and indicates which changes in intermediates bring
about the new steady state. Determination of partial
response coe⁄cients quantitates how a factor inter-
acts with the system and thereby indicates the rela-
tive importance of changes in key intermediates. This
approach yields a better understanding of how sys-
tems respond to e¡ectors, and extends MCA to help
understand how the physiological response to an ef-
fector occurs. However, it is too early to say whether
this approach will have su⁄cient predictive power to
indicate how and where to manipulate a metabolic
system to bring about a desired therapeutic or bio-
technological outcome.
4. Determining where changes in mitochondria occur
An important question in investigating mitochon-
drial physiology, pathology and pharmacology is to
determine where a physiological e¡ector, drug or
damaging agent interacts with mitochondria. Often
the ¢rst step is to measure respiration rate, mem-
brane potential or the activity of respiratory com-
plexes. These experiments frequently ¢nd changes
in a range of activities, but the signi¢cance of these
changes is often unclear. MCA has been used to help
determine how damage to individual mitochondrial
components a¡ects overall function. In using MCAC
Fig. 4. Elasticity analysis of mitochondrial respiration. In A,
the solid line shows how the membrane potential and respira-
tion rate vary as mitochondria respiring in state 4 (¢lled circle)
are gradually inhibited by titration with a respiratory inhibitor.
This curve describes the kinetics of the proton leak across the
mitochondrial inner membrane as a function of membrane po-
tential. Factors that increase the proton leak will cause such
curves to shift down and to the right while factors decreasing
the proton leak will shift such curves up and to the left (dashed
lines). In contrast, a decrease in the activity of the respiratory
chain would decrease both the respiration rate and membrane
potential, but the new steady state would lie on the original
curve (open circle). In B, the solid line shows how the mem-
brane potential and respiration rate vary as mitochondria re-
spiring in state 4 (closed circle) are exposed to a gradual in-
crease in ATP turnover until increasing ATP turnover no
longer increases respiration rate (state 3; closed circle). This
line describes the kinetics of the mitochondrial membrane po-
tential generating system as a function of membrane potential.
Factors that decrease the activity of the membrane potential
generating system will cause the curve to shift down and to the
left while factors increasing the activity of the membrane poten-
tial generating system will shift such curves up and to the right
(dashed lines). In contrast, an increase in the proton leak would
increase state 4 respiration rate and decrease the state 4 mem-
brane potential, but the new steady state would lie on the origi-
nal curve (open circle). Similarly, a decrease in the activity of
the ATP regenerating system would increase the membrane po-
tential and decrease respiration rate, but the new steady state
would lie on the same curve (open circle). The ATP regenerat-
ing system can be analysed in similar ways to the proton leak
and the membrane potential generating systems [50].
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to address these questions it is sometimes assumed
that damage to steps with large £ux control coe⁄-
cients in the undamaged system will be most impor-
tant. However, damage often leads to a redistribu-
tion of control as the system settles down to a new
steady state [48]. This makes it di⁄cult to use mea-
surements of the £ux control coe⁄cients in the un-
damaged state, or the new pattern of control in the
damaged state, to infer where damage occurred. This
is similar to the di⁄culty of using £ux control coef-
¢cients to predict where physiological e¡ectors inter-
act with mitochondria.
However, elasticity analysis can be used to show
where an e¡ector has acted on mitochondria [49].
For this, the elasticities of the three mitochondrial
subsystems (respiratory chain/substrate transport,
the phosphorylation system and the proton leak) to
the membrane potential are determined in control
and a¡ected mitochondria, just as described in top-
down analysis [7,50]. These experiments lead to plots
of the membrane potential as a function of the res-
piration rate due to the activity of the subsystem
(Fig. 4). Alterations to the activity of any of the
subsystems show up as a shift to a new curve of
membrane potential against respiration rate (Fig.
4). This analysis is particularly useful for e¡ectors
that alter more than one subsystem, and enables
their disparate e¡ects to be distinguished. Once the
site(s) of action are localised within a particular sub-
system, this analysis can be extended to ¢nd where
the e¡ector acts within the system. For example, if
elasticity analysis indicates that the respiratory chain/
substrate transport subsystem is a¡ected, then the
elasticities of the individual respiratory complexes
to their substrates and products can be determined
by appropriate inhibitor, substrate or uncoupler ti-
trations [42,51]. As was the case for the analysis of
the subsystems, a displacement from the control
curve indicates that the step has been directly altered.
Elasticity analysis has been used to determine
where a number of e¡ectors interact with mitochon-
dria. These include long-term alterations that occur
in response to changes in circulating thyroid hor-
mones [39,40], chronic exposure to ethanol [52,53]
and during the shift from weaning to adulthood in
rats [42]. Elasticity analysis has also helped to pin-
point where damage occurs to heart mitochondria
during ischaemia [48]. Another use of elasticity anal-
ysis is to determine how toxins and drugs interact
with mitochondria. For example, this approach was
used to show that chloroform a¡ects both the proton
leak and the respiratory chain [54], that some anti-
oxidants can act as both uncouplers and respiratory
inhibitors [55] and that cadmium both increased pro-
ton leak and inhibited respiration in potato mito-
chondria [50,56]. The potential of elasticity analysis
to infer where an e¡ector acts on mitochondria and
its simplicity of use make it by far the best method
available to ¢nd out where e¡ectors and damaging
agents interact with mitochondria.
5. Threshold e¡ects and the tissue speci¢c expression
of mitochondrial dysfunction
Disruption to mitochondrial function due to the
accumulation of oxidative damage and mutations
to mitochondrial DNA (mtDNA) contributes to age-
ing and degenerative diseases [5,57,58]. There is par-
ticular interest in understanding the pathology of
diseases caused by accumulation of mtDNA muta-
tions [5,59]. Because there are several hundred
mtDNA molecules per cell, a feature of mtDNA dis-
eases is heteroplasmy whereby the proportions of
mutant and undamaged mtDNA molecules vary
[5,59]. A consequence of heteroplasmy is that a pa-
tient must accumulate a mutant load above a thresh-
old value before the phenotype is expressed [5,60,61].
This threshold can be as high as 90^95% mutation
load for tRNA point mutations in cybrids [62,63] or
40^60% for tRNA point mutations in ¢broblasts or
for mtDNA deletions in cybrids [64^66]. The propor-
tion of mtDNA molecules mutated usually correlates
with decreased speci¢c activity of mitochondrial
complexes, therefore threshold values for mtDNA
mutations most likely re£ect thresholds for disrup-
tion to mitochondrial function [5,60,67].
A further feature of mtDNA diseases is their tissue
speci¢city for expression of phenotype, with post-mi-
totic tissues of high energy demand such as neurones
and muscle cells being most a¡ected [5,59,61]. Tissue
to tissue and cell to cell mosaicism for a particular
mtDNA mutation may contribute, however, homo-
plasmic mtDNA mutations and mutations in nuclear
genes for mitochondrial proteins also show tissue
speci¢c expression of phenotype [5,68]. Furthermore,
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similar tissue sensitivity to mitochondrial dysfunction
also seems to occur in other diseases associated with
respiratory complex dysfunction, such as neurode-
generative diseases and in ageing [5,69^71]. The sub-
stantial ATP demands of the a¡ected tissues no
doubt contribute to their sensitivity to defective mi-
tochondria [25,72]. As metabolic processes are di¡er-
entially a¡ected by ATP depletion, variations in
these may also render particular tissues vulnerable
to defects in mitochondrial ATP production
[31,33,73]. Finally, mitochondrial damage a¡ects oth-
er processes, such as calcium bu¡ering, radical pro-
duction and susceptibility to cell death [66,74].
Therefore, mitochondrial dysfunction may also kill
post-mitotic cells because of their vulnerability to
changes in calcium homeostasis, radical production,
or turnover of damaged mitochondria.
Respiratory complexes have thresholds for inhibi-
tion whereby mitochondrial function is only dis-
rupted when a certain proportion of the complex
has been inactivated [24,25,75^78]. As these thresh-
olds are often lower in those tissues most a¡ected by
mitochondrial damage, they may contribute to the
tissue speci¢c expression of mitochondrial damage
[24,25,75^78]. The threshold for depletion of respira-
tory complexes has been studied in vitro by titrating
complex activity with irreversible inhibitors and de-
termining how this a¡ects respiration and ATP syn-
thesis rates [24,25,75^78]. For example, the activities
of some respiratory complexes can be inhibited by
25^80% before a¡ecting respiration or ATP synthesis
in brain mitochondria [24,25] and the activity of rat
liver complex III can be decreased by 45% before
respiration is a¡ected [75]. Most interestingly, these
thresholds vary with tissue, for example the threshold
for complex III is about 45% in rat liver but only
about 5% in rat muscle [75] and similar di¡erences
have also been found for other tissues and complexes
[76,77]. These tissue variations in threshold did not
correlate with the speci¢c activities of the complexes,
and low inhibition thresholds did not always corre-
late with high £ux control coe⁄cients [24,25,75]. The
threshold e¡ects for respiratory complexes may be
related to their elasticities to their substrates and
products [75]. For example, partial inhibition of
complex III will increase the ubiquinol/ubiquinone
ratio marginally, increasing the activity of uninhib-
ited complexes because of their high elasticity to their
substrate [75]. This bu¡ers respiration in response to
complex inhibition until a certain proportion of the
complexes has been inhibited. The threshold for in-
hibition occurs when the elasticity of the complex to
its substrate decreases, consequently the complex
now has substantial £ux control and further inhibi-
tion decreases respiration. Complexes with moiety
conserved substrates such as ubiquinol/ubiquinone,
NADH/NAD or ferro-/ferricytochrome c may be
susceptible to an abrupt decrease in elasticity after
a certain proportion has been inhibited. This de-
crease in elasticity may arise because the rate of elec-
tron supply to the uninhibited complexes no longer
responds to increasing reduction of the substrate
pool after a certain proportion of the pool has
been reduced. Thus tissue speci¢c threshold e¡ects
may be due to variations in the size or redox states
of metabolite pools such as ubiquinol/ubiquinone
[75] and in the elasticities of complexes to these pools
as a function of pool redox state [79].
More work is necessary to clarify the nature of
thresholds as those found for isolated mitochondria
may not re£ect the situation in cells and whole ani-
mals, because of the saturating substrate concentra-
tions used in vitro and other changes between the cell
and the isolated mitochondria [67,80]. A further
question is why mitochondrial complexes should
have an apparent excess of capacity. It seems un-
likely that excess capacity is built into the system
to allow for damage and the apparent excess activity
may re£ect other constraints, such as maintaining
metabolite pool size to allow other pathways to
work or to prevent unwanted side reactions, such
as excessive radical production if the ubiquinol
pool becomes too reduced.
6. Summary
The application of MCA to mitochondria has led
to a system to describe how control is distributed
throughout mitochondria. This analysis does not
predict how systems are regulated in vivo, however,
this lack of predictive power is being addressed by
the development of regulation analysis. An extension
of MCA that could predict drug targets within mi-
tochondria [81,82] or where to modulate metabolic
pathways in industrially or agriculturally useful or-
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ganisms would be useful. The ¢nal component of
MCA is elasticity analysis and this elegant method-
ology shows where e¡ectors interact with mitochon-
dria. There is an increasing need to apply MCA
when studying the role of mitochondria in patholog-
ical and physiological situations. This is happening
to some extent but the use of MCA is still not wide-
spread, particularly outside Europe.
There are interesting challenges facing the applica-
tion of MCA to mitochondria. Up to now MCA has
been used to study the control of respiration and
ATP synthesis but it will be utilised to study the
control of other aspects of mitochondrial function
such as radical production and the modulation of
thermogenesis and calcium homeostasis. Another
challenge will be to integrate understanding of the
control of mitochondria with the information emerg-
ing from genomic and proteomic studies. For exam-
ple, the expression patterns of large numbers of genes
involved in mitochondrial function change in re-
sponse to p53 activation [83], and during ageing
and caloric restriction [84]. How can these large scale
changes in gene expression be interpreted and their
consequences for mitochondrial function deter-
mined? Elasticity and regulation analysis may be
able to cope when the number of genes involved is
small, but this may become impractical for a large
number of changes uncovered by oligonucleotide ar-
rays and related technologies.
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